Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (31)
Eirini Papadopoulou, Georgia Pepe, Spiridon Konitsiotis, Maria Chondrogiorgi, Nikolaos Grigoriadis, Vasilios K. Kimiskidis, Georgios Tsivgoulis, Dimos D. Mitsikostas, Elisabeth Chroni, Eleni Domouzoglou, Georgios Tsaousis & Georgios Nasioulas. (2023) The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine. Journal of the Neurological Sciences 447, pages 120609.
Crossref
Crossref
Xinran Tian. (2023) Current Development in Treatment of Spinal Muscular Atrophy. Highlights in Science, Engineering and Technology 36, pages 1474-1480.
Crossref
Crossref
Tomokazu Kimizu, Shinobu Ida, Keisuke Oki, Morimasa Shima, Shizuka Nishimoto, Ken Nakajima, Tae Ikeda, Yukiko Mogami, Keiko Yanagihara, Keiko Matsuda, Eriko Nishi, Yuiko Hasegawa, Masatoshi Nozaki, Hiroshi Fujita, Akemi Irie, Toru Katayama, Nobuhiko Okamoto, Kohsuke Imai, Hisahide Nishio & Yasuhiro Suzuki. (2023) Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study-. Brain and Development.
Crossref
Crossref
Joanna Yang, Kathryn M. Luly & Jordan J. Green. (2022)
Nonviral nanoparticle gene delivery into the
CNS
for neurological disorders and brain cancer applications
. WIREs Nanomedicine and Nanobiotechnology 15:2.
Crossref
Crossref
Georg M. Stettner, Oswald Hasselmann, Anne Tscherter, Elea Galiart, David Jacquier & Andrea Klein. (2023) Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study. BMC Neurology 23:1.
Crossref
Crossref
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, Agnese Novelli, Serena Spartano, Maria Vittoria Faggiano, Teresa Giovanniello, Antonio Angeloni, Giovanni Vento, Roberta Santoloci, Francesca Gigli, Adele D'Amico, Simonetta Costa, Alessia Porzi, Mara Panella, Chiara Ticci, Marta Daniotti, Michele Sacchini, Ilaria Boschi, Carlo Dani, Rino Agostiniani, Enrico Bertini, Antonio Lanzone, Giancarlo Lamarca, Maurizio Genuardi, Marika Pane, Maria Alice Donati, Eugenio Mercuri & Francesco Danilo Tiziano. (2022) Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis. Journal of Medical Genetics, pages jmg-2022-108873.
Crossref
Crossref
Hsing-Chuan Tsai, Violena Pietrobon, Maoyu Peng, Suning Wang, Lihong Zhao, Francesco M. Marincola & Qi Cai. (2022) Current strategies employed in the manipulation of gene expression for clinical purposes. Journal of Translational Medicine 20:1.
Crossref
Crossref
Charlotte von der Lippe, Ingrid Neteland & Kristin Billaud Feragen. (2022) Children with a rare congenital genetic disorder: a systematic review of parent experiences. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Arseniy Ya. Gayduk, Paul Cumming, Viktoriya V. Chernikova, Yan V. Vlasov & Dar’ya A. Smirnova. (2022) Complex Neuropsychiatric and Laboratory-Instrumental Diagnostics in Determination of Tactics of Therapeutic Management of Patients with Spinal Muscular Atrophy: Regional Experience. I.P. Pavlov Russian Medical Biological Herald 30:3, pages 323-334.
Crossref
Crossref
Rimma Velikanova, Simon van der Schans, Matthias Bischof, Rudolf Walther van Olden, Maarten Postma & Cornelis Boersma. (2022) Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands. Value in Health 25:10, pages 1696-1704.
Crossref
Crossref
Mihaela Axente, Andrada Mirea, Corina Sporea, Liliana Pădure, Cristina Manuela Drăgoi, Alina Crenguța Nicolae & Daniela Adriana Ion. (2022) Clinical and Electrophysiological Changes in Pediatric Spinal Muscular Atrophy after 2 Years of Nusinersen Treatment. Pharmaceutics 14:10, pages 2074.
Crossref
Crossref
Anna I. Wurz, Anna M. Schulz, Collin T. O’Bryant, Josephine F. Sharp & Robert M. Hughes. (2022) Cytoskeletal dysregulation and neurodegenerative disease: Formation, monitoring, and inhibition of cofilin-actin rods. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
John N. Milligan, Laura Blasco-Pérez, Mar Costa-Roger, Marta Codina-Solà & Eduardo F. Tizzano. (2022) Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows. Genes 13:9, pages 1657.
Crossref
Crossref
Marco Antonnio Rocha dos Santos, Samanta F. Brighente, Angela Massignan, Renata Barreto Tenório, Lorenzo Longo Makariewicz, Ana Lucila Moreira & Jonas Alex Saute. (2022) Accuracy of muscle fasciculations for the diagnosis of later-onset spinal muscle atrophy. Neuromuscular Disorders 32:9, pages 763-768.
Crossref
Crossref
Hannah A. Blair. (2022) Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy. CNS Drugs 36:9, pages 995-1005.
Crossref
Crossref
Jiaying Qiu, Liucheng Wu, Ruobing Qu, Tao Jiang, Jialin Bai, Lei Sheng, Pengchao Feng & Junjie Sun. (2022) History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy. Frontiers in Cellular Neuroscience 16.
Crossref
Crossref
Andrés López-Cortés, Gabriela Echeverría-Garcés & María José Ramos-Medina. (2022) Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy. Biology 11:6, pages 894.
Crossref
Crossref
Paola Ruffo, Sebastiano Cavallaro & Francesca Luisa Conforti. (2022) The Advent of Omics Sciences in Clinical Trials of Motor Neuron Diseases. Journal of Personalized Medicine 12:5, pages 758.
Crossref
Crossref
Yunus Arikan, Sibel Berker Karauzum, Hilmi Uysal, Ercan Mihci, Banu Nur, Ozgur Duman, Senay Haspolat, Ozden Altiok Clark & Asli Toylu. (2022) Evaluation of exonic copy numbers of SMN1 and SMN2 genes in SMA. Gene 823, pages 146322.
Crossref
Crossref
Pascal Martin, Veronka Horber, Joohyun Park, Cornelius Kronlage & Alexander Grimm. (2022) Spinale MuskelatrophieSpinal muscular atrophy. Der Nervenarzt 93:2, pages 191-200.
Crossref
Crossref
Greer K. Arthur & Glenn Cruse. (2022) Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation. International Journal of Molecular Sciences 23:2, pages 788.
Crossref
Crossref
JeanBaptiste Yaokreh, GuySerges Yapo Kouamé, Cissé Ali, Thierry-Hervé Odéhouri-Koudou & Ossénou Ouattara. (2022) Epidemiological and diagnostic characteristics of scoliosis in children in a single tertiary centre in Abidjan. African Journal of Paediatric Surgery 19:3, pages 171.
Crossref
Crossref
A.J. Gayduk, Ya.V. Vlasov & D.A. Smirnova. (2022) Application of modern approaches in the screening and early diagnosis programs for the orphan diseases. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:6, pages 30.
Crossref
Crossref
Rashin Mohseni, Amir Ali Hamidieh, Alireza Shoae-Hassani, Masood Ghahvechi-Akbari, Anahita Majma, Mahmoud Mohammadi, Mahin Nikougoftar, Reza Shervin-Badv, Jafar Ai, Hadi Montazerlotfelahi & Mahmoud Reza Ashrafi. (2021) An open-label phase 1 clinical trial of the allogeneic side population adipose-derived mesenchymal stem cells in SMA type 1 patients. Neurological Sciences 43:1, pages 399-410.
Crossref
Crossref
Joseph R. Wooley & Marta Penas-Prado. (2021) Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age. Cancers 13:24, pages 6313.
Crossref
Crossref
Ramona De Amicis, Giovanni Baranello, Andrea Foppiani, Alessandro Leone, Alberto Battezzati, Giorgio Bedogni, Simone Ravella, Ester Giaquinto, Chiara Mastella, Caterina Agosto, Enrico Bertini, Adele D’Amico, Marina Pedemonte, Claudio Bruno, Jonathan C. Wells, Mary Fewtrell & Simona Bertoli. (2021) Growth patterns in children with spinal muscular atrophy. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Andrada Mirea, Elena-Silvia Shelby, Mihaela Axente, Mihaela Badina, Liliana Padure, Madalina Leanca, Vlad Dima & Corina Sporea. (2021) Combination Therapy with Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type I. Journal of Clinical Medicine 10:23, pages 5540.
Crossref
Crossref
Vanessa Luiza Romanelli Tavares, Frederico Monfardini, Naila Cristina Vilaça Lourenço, Katia Maria da Rocha, Karina Weinmann, Rita Pavanello & Mayana Zatz. (2021) Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. International Journal of Neonatal Screening 7:3, pages 53.
Crossref
Crossref
Gayatri Gandhi, Syahril Abdullah, Agus Iwan Foead & Wendy Wai Yeng Yeo. (2021) The potential role of miRNA therapies in spinal muscle atrophy. Journal of the Neurological Sciences 427, pages 117485.
Crossref
Crossref
Sara Salucci, Anna Bartoletti Stella, Michela Battistelli, Sabrina Burattini, Alberto Bavelloni, Lucio Ildebrando Cocco, Pietro Gobbi & Irene Faenza. (2021) How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders. Biomolecules 11:8, pages 1109.
Crossref
Crossref
Russell J. Butterfield. (2021) Spinal Muscular Atrophy Treatments, Newborn Screening, and the Creation of a Neurogenetics Urgency. Seminars in Pediatric Neurology 38, pages 100899.
Crossref
Crossref